awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24658334-8EE1046C-2205-49B4-9540-3C6A8FD5EDE5
Q24658334-8EE1046C-2205-49B4-9540-3C6A8FD5EDE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658334-8EE1046C-2205-49B4-9540-3C6A8FD5EDE5
Targeting the mTOR signaling network for cancer therapy
P2860
Q24658334-8EE1046C-2205-49B4-9540-3C6A8FD5EDE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658334-8EE1046C-2205-49B4-9540-3C6A8FD5EDE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8692ed8e82608d8af8a1bda9fa34024e93246193
P2860
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (